BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 1899380)

  • 1. The human dioxin-inducible NAD(P)H: quinone oxidoreductase cDNA-encoded protein expressed in COS-1 cells is identical to diaphorase 4.
    Shaw PM; Reiss A; Adesnik M; Nebert DW; Schembri J; Jaiswal AK
    Eur J Biochem; 1991 Jan; 195(1):171-6. PubMed ID: 1899380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6.
    Jaiswal AK; Burnett P; Adesnik M; McBride OW
    Biochemistry; 1990 Feb; 29(7):1899-906. PubMed ID: 1691923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human dioxin-inducible cytosolic NAD(P)H:menadione oxidoreductase. cDNA sequence and localization of gene to chromosome 16.
    Jaiswal AK; McBride OW; Adesnik M; Nebert DW
    J Biol Chem; 1988 Sep; 263(27):13572-8. PubMed ID: 2843525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAD(P)H: quinone oxidoreductase (DT-diaphorase) in chick embryo liver. Comparison to activity in rat and guinea pig liver and differences in co-induction with 7-ethoxyresorufin deethylase by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Spencer CB; Rifkind AB
    Biochem Pharmacol; 1990 Jan; 39(2):327-35. PubMed ID: 2105732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAD(P)H:quinone oxidoreductase 1 reduces the mutagenicity of DNA caused by NADPH:P450 reductase-activated metabolites of benzo(a)pyrene quinones.
    Joseph P; Jaiswal AK
    Br J Cancer; 1998 Mar; 77(5):709-19. PubMed ID: 9514048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase.
    Joseph P; Jaiswal AK
    Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8413-7. PubMed ID: 8078896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of expression of the NAD(P)H:quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same origin.
    Cresteil T; Jaiswal AK
    Biochem Pharmacol; 1991 Aug; 42(5):1021-7. PubMed ID: 1651729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of mammalian DT-diaphorase in Escherichia coli: purification and characterization of the expressed protein.
    Ma Q; Wang R; Yang CS; Lu AY
    Arch Biochem Biophys; 1990 Dec; 283(2):311-7. PubMed ID: 1703398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones.
    Gustafson DL; Beall HD; Bolton EM; Ross D; Waldren CA
    Mol Pharmacol; 1996 Oct; 50(4):728-35. PubMed ID: 8863816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human NAD(P)H:quinone oxidoreductase2. Gene structure, activity, and tissue-specific expression.
    Jaiswal AK
    J Biol Chem; 1994 May; 269(20):14502-8. PubMed ID: 8182056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AP-2-mediated regulation of human NAD(P)H: quinone oxidoreductase 1 (NQO1) gene expression.
    Xie T; Jaiswal AK
    Biochem Pharmacol; 1996 Mar; 51(6):771-8. PubMed ID: 8602872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of FMN-dependent NADH-quinone reductase induced by menadione in Escherichia coli.
    Hayashi M; Hasegawa K; Oguni Y; Unemoto T
    Biochim Biophys Acta; 1990 Aug; 1035(2):230-6. PubMed ID: 2118386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of NAD(P)H:quinone oxidoreductase 1 (DT diaphorase) in protection against quinone toxicity.
    Joseph P; Long DJ; Klein-Szanto AJ; Jaiswal AK
    Biochem Pharmacol; 2000 Jul; 60(2):207-14. PubMed ID: 10825465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinoneimines as substrates for quinone reductase (NAD(P)H: (quinone-acceptor)oxidoreductase) and the effect of dicumarol on their cytotoxicity.
    Powis G; See KL; Santone KS; Melder DC; Hodnett EM
    Biochem Pharmacol; 1987 Aug; 36(15):2473-9. PubMed ID: 2440444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAD(P)H-dependent quinone oxidoreductase 1 (NQO1) and cytochrome P450 oxidoreductase (CYP450OR) differentially regulate menadione-mediated alterations in redox status, survival and metabolism in pancreatic β-cells.
    Gray JP; Karandrea S; Burgos DZ; Jaiswal AA; Heart EA
    Toxicol Lett; 2016 Nov; 262():1-11. PubMed ID: 27558805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and partial purification of microsomal NAD(P)H:quinone oxidoreductases.
    Jaiswal AK
    Arch Biochem Biophys; 2000 Mar; 375(1):62-8. PubMed ID: 10683249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reductive metabolism of diaziquone (AZQ) in the S9 fraction of MCF-7 cells: free radical formation and NAD(P)H: quinone-acceptor oxidoreductase (DT-diaphorase) activity.
    Fisher GR; Gutierrez PL
    Free Radic Biol Med; 1991; 10(6):359-70. PubMed ID: 1654286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a new isogenic cell-xenograft system for evaluation of NAD(P)H:quinone oxidoreductase-directed antitumor quinones: evaluation of the activity of RH1.
    Dehn DL; Winski SL; Ross D
    Clin Cancer Res; 2004 May; 10(9):3147-55. PubMed ID: 15131056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations.
    den Braver-Sewradj SP; den Braver MW; Toorneman RM; van Leeuwen S; Zhang Y; Dekker SJ; Vermeulen NPE; Commandeur JNM; Vos JC
    Chem Res Toxicol; 2018 Feb; 31(2):116-126. PubMed ID: 29281794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse dioxin-inducible NAD(P)H: menadione oxidoreductase: NMO1 cDNA sequence and genetic differences in mRNA levels.
    Vasiliou V; Theurer MJ; Puga A; Reuter SF; Nebert DW
    Pharmacogenetics; 1994 Dec; 4(6):341-8. PubMed ID: 7704040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.